Technetium-99m sestamibi in chronic coronary artery disease: the European experience.
Am J Cardiol
; 66(13): 91E-96E, 1990 Oct 16.
Article
em En
| MEDLINE
| ID: mdl-2145754
ABSTRACT
Since the introduction of technetium-99m methoxy-isobutyl isonitrile (Tc-99m sestamibi) in Europe, there has been a growing interest in its use. Several European multicenter trials have been conducted to evaluate this new agent in relation to the traditional perfusion marker thallium-201, and other studies are in progress to understand the use of this perfusion marker for the diagnosis of coronary disease, for use in conjunction with pharmacologic vasodilation, for use in the assessment of ventricular function and wall motion and for the assessment of interventions.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Compostos de Organotecnécio
/
Doença das Coronárias
/
Coração
/
Nitrilas
Tipo de estudo:
Clinical_trials
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Ano de publicação:
1990
Tipo de documento:
Article